A Phase 1-2, Open-label, Multicenter Study to Evaluate Safety, Tolerability, Pharmacokinetics and Efficacy of Oral Once-Daily Administration of HS10296 in Patients with Locally Advanced or Metastatic Non- Small-Cell Lung Cancer Who Have Progressed Follow

  • Willis, Maurice, (PI)

    Project: Other project

    StatusFinished
    Effective start/end date5/27/175/26/19